-
Mashup Score: 5Switching from vitamin K antagonist to dabigatran in atrial fibrillation: differences according to dose - 3 year(s) ago
AbstractAims. In atrial fibrillation (AF) patients 150 mg b.i.d. dabigatran is the standard dose, yet guidelines recommend 110 mg b.i.d. when bleeding risk is h
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Switching from vitamin K antagonist to dabigatran in atrial fibrillation: differences according to dose - 3 year(s) ago
AbstractAims. In atrial fibrillation (AF) patients 150 mg b.i.d. dabigatran is the standard dose, yet guidelines recommend 110 mg b.i.d. when bleeding risk is h
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Left ventricular thrombus (LVT) is a frightening complication primarily occurring in patients with LV dysfunction following a large myocardial infarction (MI).
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1
Background and purpose Real-world data about treatment convenience and satisfaction in Asian non-valvular atrial fibrillation (NVAF) patients after switching from vitamin K antagonists (VKAs) to non-VKA oral anticoagulants were evaluated. Methods In this non-interventional study involving 49 sites across five countries in Southeast Asia and South Korea, 379 stable NVAF patients who switched from…
Source: Open HeartCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Anticoagulation control with the point-of-care INR: A retrospective pre-/post-analysis - 4 year(s) ago
Highlights•Point-of-care (POC) international normalized ratio (INR) testing provides immediate results.•It is still debated whether POC-INR monitoring can improve the time in therapeutic range (TTR).•We evaluated the TTR from 471 warfarin patients in three timeframes (pre-POC, initial-POC, steady-state-POC).•Compared to laboratory-INR, POC-INR monitoring increased the TTR both in the short- and…
Source: www.sciencedirect.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
"The right dose to the right patient" Switching from #VKA to #dabigatran in atrial fibrillation: differences according to dose https://t.co/gr5qVWpJwB